Assess the impact of headache disorders on quality of life using the MIDAS tool
The migraine disability assessment (MIDAS) tool is available in your EHR as a brief self-administered questionnaire designed to efficiently measure the impact of migraine and other primary headache disorders on patients’ lives and to quantify headache-related disability.1
Using the MIDAS tool is easy
Complete the assessment
Your EHR will tabulate the MIDAS grade based on your patient’s responses to questions 1-5, and display the score and results in the patient’s chart.
0 to 5: MIDAS Grade I, Little or no disability
6 to 10: MIDAS Grade II, Mild disability
11 to 20: MIDAS Grade III, Moderate disability
21+: MIDAS Grade IV, Severe disability
A follow-up discussion of the patient’s level of disability due to chronic headache is recommended for a score greater than 0. Click on the “Migraine disability assessment test” in blue to complete the assessment details pane.
Learn more about the MIDAS tool
The MIDAS questionnaire was created to help measure the impact headaches have on a person’s life. It was developed by Richard B. Lipton, MD, Professor of Neurology, Albert Einstein College of Medicine, New York, NY, and Walter F. Stewart, MPH, PhD, Associate Professor of Epidemiology, Johns Hopkins University, Baltimore, MD.1
You can familiarize yourself with the MIDAS tool before a patient encounter by accessing a PDF versionor navigating to Screenings/interventions/assessments in your EHR, selecting Add item and searching for “MIDAS”:
Your EHR comes with clinical decision support (CDS) that gives you easy access to the MIDAS tool
A CDS notification will display during the patient visit if your patient’s medical history matches potential clinical markers of migraine or other primary headache disorders. From this notification you can easily access the MIDAS tool.
- Stewart WF1, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56:S20-8.